Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIOCHROM LTD

Biochrom Ltd. is a leading manufacturer of scientific instruments with over 40 years experience. The Biochrom Group c... read more Featured Products: More products

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

LAMP Technique Detects Toxoplasmosis

By LabMedica International staff writers
Posted on 16 Jun 2015
The analytical sensitivity and specificity of a newly described DNA amplification technique, loop-mediated isothermal amplification (LAMP), has been tested for the diagnosis of toxoplasmosis. More...


Toxoplasma gondii is an obligate intracellular protozoan parasite capable of infecting humans and all warm blooded animals worldwide and despite the high rate of infection in human, infections often remain asymptomatic in immunocompetent individuals.

Scientists at the Lorestan University of Medical Sciences (Khorramabad, Iran) prepared T. gondii tachyzoites from peritoneal exudate from infected mice. Extraction of DNA was performed using the classical phenol chloroform extraction, and two commercial DNA extraction kits. A Nano-spectrophotometer WPA-Biowave II (Biochrom; Cambridge, UK) was used to determine the concentration and quality of the DNA. Each T. gondii one 80-Mbp genome was assumed equal about 80 fg DNA.

The analytical sensitivity of LAMP and nested-polymerase chain reaction (PCR) was obtained against 10-fold serial dilutions of T. gondii DNA ranging from 1 ng to 0.01 fg. DNA samples of other parasites and human chromosomal DNA were used to determine the specificity of molecular assays. The team analyzed the sensitivity, specificity and technical performances of the LAMP and nested-PCR assays by targeting the two repetitive conserved regions (RE and B1) in the Toxoplasma genome for the molecular diagnosis of T. gondii infection.

After testing LAMP and nested-PCR in duplicate, the detection limit of RE-LAMP, B1-LAMP, RE-nested PCR and B1-nested PCR assays was one fg, 100 fg, 1 pg and 10 pg of T. gondii DNA respectively. All the LAMP assays and nested PCRs were 100% specific. The RE-LAMP assay was the most sensitive for the detection of T. gondii DNA.

The authors concluded the LAMP technique has a greater sensitivity for detection of T. gondii. Furthermore, these findings indicate that primers based on the RE are more suitable than those based on the B1 gene. However, the B1-LAMP assay has potential as a diagnostic tool for detection of T. gondii. Because of its simplicity, sensitivity, and specificity, LAMP is suggested as an appropriate method for the routine molecular diagnosis of toxoplasmosis. The study was published on May 20, 2015, in the Asian Pacific Journal of Tropical Medicine.

Related Links:

Lorestan University of Medical Sciences 
Biochrom 




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.